Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Clarient's Ovotax test may help improve patients’ response to taxane therapy

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.

17 Mar 2010

BeaconEquity.com: CTIC' total net operating expenses for fourth-quarter of 2009 are $26.2M

BeaconEquity.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

17 Mar 2010

Circulating tumor cells could help guide treatment and improve quality of life for cancer patients

One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.

17 Mar 2010

Cervical cancer vaccine may protect females from post-surgical recurrence

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham (UAB).

17 Mar 2010

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

AstraZeneca Canada announces the recently approved indication for IRESSA(R), a once-daily oral targeted therapy for the first-line treatment of patients with locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the epidermal growth factor receptor-tyrosine kinase (EGFR-TK). In conjunction with this approval, AstraZeneca is also announcing the availability of a diagnostic test which can now determine a patient's EGFR mutation status, representing a new era in personalized lung cancer treatment in Canada.

17 Mar 2010

Low-income patients with brain tumors are less likely to be referred to specialty hospitals

African-American, Hispanic, and economically disadvantaged patients with brain tumors are significantly less likely to be referred to high-volume hospitals that specialize in neurosurgery than other patients of similar age, the same gender, and with similar comorbidities, according to new research by Johns Hopkins doctors.

17 Mar 2010

Hikma Pharmaceuticals announces 36% increase in operating profits for 2009

Hikma Pharmaceuticals today announced 2009 preliminary results with operating profits up 36% on the back of a strong performance from its Middle East markets.

17 Mar 2010

Despite increasing palliative care resources, significant gaps in care delivery remain

Palliative care services are available at most U.S. cancer centers, although the scope of services offered and the degree of integration between palliative care and oncology care varies widely among centers, according to a study in the March 17 issue of JAMA, a theme issue on cancer.

17 Mar 2010

Radiofrequency ablation helps prolong life of colorectal cancer patients

Approximately half of Americans living with colorectal cancer will develop liver metastases at some point during the course of their disease. Radiofrequency ablation, a minimally invasive treatment that applies heat directly in the tumor causing cancer cell death with minimal associated injury to the surrounding healthy liver, contributes to prolongation of their life by nearly three years, note researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

17 Mar 2010

Patent applications continue to alter medical landscape to improve patient care

Over the past 40 years, more than 2,400 patents and patent applications-pioneering modern medicine with the devices and drugs that advance minimally invasive treatments-have been filed by members of the Society of Interventional Radiology.

17 Mar 2010

Primary results of CABG sub-analysis presented at ACC meeting

AstraZeneca (NYSE: AZN) today announced results of a new analysis of the PLATO (A Study of PLATelet Inhibition and Patient Outcomes) study which showed there were fewer deaths in patients with acute coronary syndromes (ACS) who took the investigational oral antiplatelet ticagrelor (BRILINTA™/BRILIQUE™) within seven days prior to having heart bypass surgery (coronary artery bypass graft, CABG) compared to those who took clopidogrel.

17 Mar 2010

NCCN Guidelines translated into Japanese

The NCCN Clinical Practice Guidelines in Oncology have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines™ are being translated into Japanese. The Translational Research Informatics Center Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer of the Colon and Rectum, has translated the NCCN Guidelines for Colon Cancer and Rectal Cancer, which are now available online.

17 Mar 2010

Novel procedure opens door to new and future treatment for pancreatic cancer

Pancreatic cancer-known as the most fatal cancer with no known effective treatment-requires a radical new therapy. A promising approach may come in the form of tiny gold nanoparticles-loaded with a therapeutic agent to kill cancer-in a novel procedure called "nanoembolization," said researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

17 Mar 2010

Methamphetamine abuse during pregnancy leads to structural abnormalities in brain of children

It has long been known that alcohol exposure is toxic to the developing fetus and can result in lifelong brain, cognitive and behavioral problems. Now, a new report out of UCLA shows that the effects of prenatal methamphetamine exposure - or worse, a combination of methamphetamine and alcohol - may be even more damaging.

17 Mar 2010

MedSolutions launches oncology management program for cancer patients

MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.

17 Mar 2010

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham.

17 Mar 2010

Cryotherapy offers potential treatment options for breast cancer patients

Interventional radiologists have opened the door to an encouraging potential future treatment for the nearly 200,000 women who are diagnosed with breast cancer in the United States each year: image-guided, multiprobe cryotherapy.

17 Mar 2010

Varian Medical Systems chooses EasyLink as provider for hosted fax services

EasyLink Services International Corporation, a premier global provider of comprehensive messaging services and e-commerce solutions, announced today that Varian Medical Systems has selected EasyLink as its provider for hosted fax services for an initial three-year term.

16 Mar 2010

Epeius Biotechnologies' tumor-targeted vaccine technology for cancer immunotherapy receives patent protection

Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.

16 Mar 2010

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced publication of data from a preclinical study in a clinically relevant animal model of sepsis showing that recombinant human Interleukin-7 (rhIL-7) treatment not only restores T cell trafficking and function, but also translates into improved survival.

16 Mar 2010

Oncology News and Research

Further Reading

Clarient's Ovotax test may help improve patients’ response to taxane therapy

BeaconEquity.com: CTIC' total net operating expenses for fourth-quarter of 2009 are $26.2M

Circulating tumor cells could help guide treatment and improve quality of life for cancer patients

Cervical cancer vaccine may protect females from post-surgical recurrence

AstraZeneca Canada's IRESSA receives approval for treatment of NSCLC

Low-income patients with brain tumors are less likely to be referred to specialty hospitals

Hikma Pharmaceuticals announces 36% increase in operating profits for 2009

Despite increasing palliative care resources, significant gaps in care delivery remain

Radiofrequency ablation helps prolong life of colorectal cancer patients

Patent applications continue to alter medical landscape to improve patient care

Primary results of CABG sub-analysis presented at ACC meeting

NCCN Guidelines translated into Japanese

Novel procedure opens door to new and future treatment for pancreatic cancer

Methamphetamine abuse during pregnancy leads to structural abnormalities in brain of children

MedSolutions launches oncology management program for cancer patients

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

Cryotherapy offers potential treatment options for breast cancer patients

Varian Medical Systems chooses EasyLink as provider for hosted fax services

Epeius Biotechnologies' tumor-targeted vaccine technology for cancer immunotherapy receives patent protection

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cancer Research eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News